White Lion Capital LLC → CID Holdco, Inc. DAICW

Stake: — Shares: — Class: Common Stock, par value $0.0001 per share

Composite Decision Signal · AVOID (DILUTION / EXIT TRAP) Conviction Score: 17/100

Disqualifiers: ACTIVE_DILUTION_SHELF: Active 424B5 / S-3 shelf takedown within ±30d

Passive Schedule 13G filer baseline
Material 8-K governance/transaction event (Item 5.02 / 1.01 / 2.01) within ±30d
Short interest building (+50.1% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

3 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

38,647 shares short · +50.1% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-10-09	Nambiar Vijayan	officer	J	18,634	—	—
2026-10-09	Nabrotzky Edmund S.	director, officer	J	18,634	—	—
2026-10-09	Maddox Charles K.	officer	J	18,345	—	—

Other Filings by White Lion Capital LLC

Filed	Form	Issuer	Stake	Shares
2026-09-02	SCHEDULE 13G	Glucotrack, Inc.	—	—	view →
2026-08-07	SCHEDULE 13G	Akari Therapeutics Plc	—	—	view →
2026-07-09	SCHEDULE 13G	Actelis Networks, Inc. ASNS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →